Therefore, this study examined polymorphism of the CD20 gene in Chinese DLBCL population and the relationship between the polymorphism and clinical efficacy in patients with DLBCL treated with R-CHOP. This evidence concerns the gene MS4A1 and diffuse large B-cell lymphoma.